Boltz

Boston, MA · Founded 2024 · Privately Held (backing)

Operator of an AI-based biotechnology company designed to accelerate drug discovery from hit identification to lead optimization. Boltz is based in Boston, MA and was founded in 2024. Its last reported valuation was $130 million in Jan 2026. It has raised $28 million.

Last reported valuation
$130.0M
Oct 2026
Priced at
—
Total raised
$28.0M
Last round
—

Who backs Boltz?

6 investors
InvestorType
Andreessen HorowitzVenture capital
Amplify PartnersVenture capital
Obvious VenturesVenture capital
Clément Delangue—
Factorial Capital—
Zetta Venture Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Boltz investors

6 investors are on record for Boltz, including Andreessen Horowitz, Amplify Partners, Obvious Ventures and Clément Delangue.

Free account
More of Boltz with a free account
  • ·Watch Boltz: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Boltz. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View